GENCELL BIOSYSTEMS LTD.
13Patents
13Active
13Granted
50Portfolio score
Filing activity: Jul 22, 2011 → Aug 2, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8465707B2 | Composite liquid cells | Emerging Cross-Sectional Technologies | 9 | Active |
| US10207271B2 | Benchtop nucleic acid library preparation device and methods for using the same | Performing Operations; Transporting | 3 | Active |
| US9776182B2 | Handling liquid samples | Performing Operations; Transporting | 2 | Active |
| US10384187B2 | Composite liquid cell (CLC) mediated nucleic acid library preparation device, and methods for using the same | Chemistry; Metallurgy | 2 | Active |
| US9777269B2 | Biomolecule isolation | Physics | 1 | Active |
| US9080208B2 | Composite liquid cells | Emerging Cross-Sectional Technologies | 1 | Active |
| US10143989B2 | Stabilisation features | Chemistry; Metallurgy | 0 | Active |
| US10081808B2 | Biomolecule isolation | Physics | 0 | Active |
| US10252261B2 | Handling liquid samples | Performing Operations; Transporting | 0 | Active |
| US10125389B2 | Composite liquid cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US9493816B2 | Composite liquid cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US10266878B2 | Genomic analysis device and methods of use | Performing Operations; Transporting | 0 | Active |
| US10722879B2 | Magnetic separation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.